Ian D. Kerr
- Molecular Biology top 2%
- Oncology top 2%
- Plant Science top 5%
- Infectious Diseases top 5%
- Surgery top 10%
- Co-authors
- Mark S.P. SansomRichard CallaghanChris P. PontingFrederica L. TheodoulouRamasubbu SankararamakrishnanJ. BreedMalcolm J. BennettRobert C. Ford
- Topics
- Drug Transport and Resistance Mechanisms (52 papers)Lipid Membrane Structure and Behavior (15 papers)HIV/AIDS drug development and treatment (14 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- United KingdomAustraliaCanada
In The Last Decade
Ian D. Kerr
121 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 136
- Molecular Biology 3.1k
- Oncology 1.6k
- Plant Science 758
- Infectious Diseases 434
- Surgery 339
Countries citing papers authored by Ian D. Kerr
This map shows the geographic impact of Ian D. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian D. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian D. Kerr more than expected).
Fields of papers citing papers by Ian D. Kerr
This network shows the impact of papers produced by Ian D. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian D. Kerr. The network helps show where Ian D. Kerr may publish in the future.
Co-authorship network of co-authors of Ian D. Kerr
This figure shows the co-authorship network connecting the top 25 collaborators of Ian D. Kerr. A scholar is included among the top collaborators of Ian D. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian D. Kerr. Ian D. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 15 | |
| 5 | 7 | |
| 6 | 17 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 44 | |
| 10 | 155 | |
| 11 | 7 | |
| 12 | 4 | |
| 13 | 79 | |
| 14 | 29 | |
| 15 | 96 | |
| 16 | 51 | |
| 17 | 113 | |
| 18 | 121 | |
| 19 | 33 | |
| 20 | 74 |
About Ian D. Kerr
Ian D. Kerr is a scholar working on Oncology, Microbiology and Molecular Medicine, having authored 123 papers that have together received 4.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (52 papers), Lipid Membrane Structure and Behavior (15 papers) and HIV/AIDS drug development and treatment (14 papers). The work is most often cited by research in Oncology (1.6k citations), Molecular Biology (3.1k citations) and Molecular Medicine (212 citations). Ian D. Kerr has collaborated with scholars based in United Kingdom, Australia and Canada. Frequent co-authors include Mark S.P. Sansom, Richard Callaghan, Chris P. Ponting, Frederica L. Theodoulou, Ramasubbu Sankararamakrishnan, J. Breed, Malcolm J. Bennett, Robert C. Ford, Alice J. Rothnie and Hyeon S. Son. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.